Skip to Content
You are currently on the new version of our website. Access the old version .

3 Results Found

  • Article
  • Open Access
2 Citations
1,564 Views
13 Pages

Delayed vs. Concomitant Urethrectomy for Non-Metastatic Urothelial Carcinoma of the Urinary Bladder Undergoing Radical Cystectomy: Perioperative and Survival Outcomes from a Single Tertiary Centre in the United Kingdom

  • Francesco Del Giudice,
  • Mohamed Gad,
  • Valerio Santarelli,
  • Rajesh Nair and ,
  • Yasmin Abu-Ghanem,
  • Elsie Mensah,
  • Ben Challacombe,
  • Jonathan Kam,
  • Youssef Ibrahim and
  • Muhammad Shamim Khan
  • + 19 authors+ 14 authors

14 August 2025

Introduction: The role of urethrectomy at the time of Robotic-Assisted or Open Radical Cystectomy (RARC, ORC) is controversial. Whether urethrectomy should be performed at the time of RARC/ORC or delayed up to a 3–6 month interval is unclear. W...

  • Article
  • Open Access
1,630 Views
13 Pages

Real-World Treatment Patterns and Outcomes of Intraluminal Ablative Therapies in Noninvasive Urethral Carcinoma: A National Cancer Database Analysis

  • Eusebio Luna Velasquez,
  • Vatsala Mundra,
  • Renil S. Titus,
  • Jiaqiong Xu and ,
  • Carlos Riveros,
  • Dharam Kaushik,
  • Amar Singh,
  • Suran Somawardana,
  • Christopher J. D. Wallis and
  • Raj Satkunasivam
  • + 5 authors+ 0 author

Objective: To evaluate treatment patterns, predictors of treatment selection, and overall survival (OS) in patients with noninvasive (Ta–Tis) urothelial carcinoma of the urethra (UUC). Patients and Methods: We conducted a retrospective cohort s...

(This article belongs to the Section Genitourinary Oncology)
  • Article
  • Open Access
5 Citations
3,135 Views
14 Pages

Concomitant Immunotherapy and Metastasis-Directed Radiotherapy in Upper Tract Urothelial Carcinoma: A Biomarker-Driven, Original, Case-Based Proof-of-Concept Study

  • Gaetano Pezzicoli,
  • Francesco Salonne,
  • Vittoria Musci,
  • Federica Ciciriello and ,
  • Stefania Tommasi,
  • Rosanna Lacalamita,
  • Alfredo Zito,
  • Sara Antonia Allegretta,
  • Antonio Giovanni Solimando and
  • Mimma Rizzo
  • + 5 authors+ 0 author

18 December 2023

Metastatic upper tract urothelial carcinoma (mUTUC) has a poor prognosis. Immune checkpoint inhibitors (ICIs) have demonstrated efficacy in patients with metastatic urothelial carcinoma. However, data supporting the use of ICIs in patients with mUTUC...

(This article belongs to the Section Hematology)